While many employer plans cover the headline-grabbing Ozempic and similar drugs as a diabetes treatment, just 22% of U.S. employers cover any kind of prescription drugs for weight loss—for which Ozempic and cousins Wegovy and Rybelsus are increasingly prescribed.
